Custom Health Delivers US$51.6 Million Proforma Annualized Revenue Run-Rate in Q1-2026

Source Summary

For the three months ended March 31, 2026, Custom Health achieved quarterly revenue of US$4.3 million, while InnovativeRx (as defined below) achieved record quarterly revenue of US$8.6 million, reflecting total consolidated quarterly revenue of US$12.9 million and proforma annualized revenue run-rate(1) of US$51.6 million. Custom Health successfully completed its public listing and started trading on the Toronto Stock Exchange on June 24,